College of Life Sciences and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China.
Institute of Pathogen Biology and Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Front Cell Infect Microbiol. 2018 Feb 26;8:51. doi: 10.3389/fcimb.2018.00051. eCollection 2018.
The deep hydrophobic pocket of HIV-1 gp41 has been considered a drug target, but short-peptides targeting this site usually lack potent antiviral activity. By applying the M-T hook structure, we previously generated highly potent short-peptide fusion inhibitors that specifically targeted the pocket site, such as MT-SC22EK, HP23L, and LP-11. Here, the crystal structures of HP23L and LP-11 bound to the target mimic peptide N36 demonstrated the critical intrahelical and interhelical interactions, especially verifying that the hook-like conformation was finely adopted while the methionine residue was replaced by the oxidation-less prone residue leucine, and that addition of an extra glutamic acid significantly enhanced the binding and inhibitory activities. The structure of HP23L bound to N36 with two mutations (E49K and L57R) revealed the critical residues and motifs mediating drug resistance and provided new insights into the mechanism of action of inhibitors. Therefore, the present data help our understanding for the structure-activity relationship (SAR) of HIV-1 fusion inhibitors and facilitate the development of novel antiviral drugs.
HIV-1 gp41 的深疏水性口袋一直被认为是一个药物靶点,但针对该位点的短肽通常缺乏有效的抗病毒活性。通过应用 M-T 钩结构,我们之前生成了针对口袋位点的高活性短肽融合抑制剂,如 MT-SC22EK、HP23L 和 LP-11。在这里,HP23L 和 LP-11 与靶模拟肽 N36 结合的晶体结构表明了关键的螺旋内和螺旋间相互作用,特别是证实了当甲硫氨酸残基被不易氧化的亮氨酸取代时,钩状构象被精细地采用,并且额外添加一个谷氨酸显著增强了结合和抑制活性。HP23L 与具有两个突变(E49K 和 L57R)的 N36 结合的结构揭示了介导耐药性的关键残基和基序,并为抑制剂的作用机制提供了新的见解。因此,目前的数据有助于我们理解 HIV-1 融合抑制剂的结构-活性关系(SAR),并促进新型抗病毒药物的开发。